{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:00:33Z","timestamp":1790834433400,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82305020, 82374319"],"award-info":[{"award-number":["82305020, 82374319"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515140123, 2025A04J3706, 2025A04J5156"],"award-info":[{"award-number":["2024A1515140123, 2025A04J3706, 2025A04J5156"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gegen Qinlian Decoction (GQD) is used to treat intestinal disorders, but its mechanism in ulcerative colitis (UC) induced by combined high-fat diet (HFD) and dextran sulfate sodium (DSS) exposure remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A UC mouse model was induced by HFD plus DSS. GQD constituents were identified by UPLC\u2013MS\/MS. Colonic pathology and barrier integrity were assessed by H&amp;amp;E and immunofluorescence. Gut microbiota and bile acids were analyzed by 16S rRNA gene sequencing and targeted metabolomics. Transcriptomics, ELISA, Western blotting, fecal microbiota transplantation (FMT), and molecular docking were used to investigate mechanisms. LPS-stimulated Caco-2 cells were treated with 20 or 50 \u03bcM DCA; cell viability, NLRP3 inflammasome-related gene expression, and ZO-1\/Occludin immunofluorescence were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      GQD ameliorated gut dysbiosis, decreasing the Firmicutes\/Bacteroidetes ratio, increasing\n                      <jats:italic>Akkermansia muciniphila<\/jats:italic>\n                      , and reducing\n                      <jats:italic>Clostridium perfringens<\/jats:italic>\n                      . It remodeled bile acid metabolism, decreasing primary bile acids (CA, TCA, and CDCA, etc.) and increasing secondary bile acids (DCA, 6,7-DKLCA and 3\u03b2-DCA, etc.). Transcriptomics indicated inhibition of NOD-like receptor signaling. GQD suppressed NLRP3 inflammasome activation and reduced ASC, pro-caspase-1, cleaved caspase-1, GSDMD-N, and IL-18. Docking prioritized DCA as a candidate NLRP3-interacting metabolite. In Caco-2 cells, DCA dose-dependently reduced LPS-induced NLRP3, ASC, GSDMD, IL1B, and IL18 mRNA expression and partially restored ZO-1 and Occludin signals without appreciable cytotoxicity. FMT supported the involvement of gut microbiota in GQD-mediated anti-inflammatory effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GQD alleviates UC induced by combined HFD and DSS exposure by reshaping the gut microbiota and correcting bile acid dysregulation, thereby inhibiting NLRP3 inflammasome activation. This study highlights the gut microbiota\u2013bile acid axis in GQD\u2019s therapeutic effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1895206","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:42:25Z","timestamp":1790833345000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gegen Qinlian decoction alleviates ulcerative colitis by remodeling the gut microbiota-bile acid axis and inhibiting NLRP3-mediated pyroptosis"],"prefix":"10.3389","volume":"17","author":[{"given":"Hao","family":"Wang","sequence":"first","affiliation":[{"name":"School of Traditional Chinese Medicine, Jinan University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosen","family":"Ou","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Jinan University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huachong","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Jinan University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangjuan","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Jinan University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Jinan University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Jinan University","place":["Guangzhou, China"]},{"name":"Postdoctoral Station of Clinical Medicine, The First Affiliated Hospital of Jinan University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Jinan University","place":["Guangzhou, China"]},{"name":"Postdoctoral Station of Clinical Medicine, The First Affiliated Hospital of Jinan University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Basic Medicine and Public Health, Jinan University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Deng","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Jinan University","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization, Jinan University","place":["Guangzhou, China"]},{"name":"Guangzhou Key Laboratory of Formula-Pattern of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Jinan University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Jinan University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003463","article-title":"ACG clinical guideline update: Ulcerative colitis in adults","volume":"120","author":"Rubin","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00183","article-title":"A systematic review of epidemiology and risk factors associated with Chinese inflammatory bowel disease","volume":"5","author":"Cui","year":"2018","journal-title":"Front Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"24408","DOI":"10.1038\/s41598-025-09896-x","article-title":"Cirsiliol alleviates experimental inflammatory bowel disease via restoration of intestinal barrier integrity and inhibition of NF-\u03baB and MAPK pathways","volume":"15","author":"Gao","year":"2025","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.181","article-title":"Obesity in IBD: Epidemiology, pathogenesis, disease course and treatment outcomes","volume":"14","author":"Singh","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02392-25","article-title":"Lactobacillus plantarum Lac16 alleviates dextran sodium sulfate-induced colitis in mice by suppressing NLRP3 inflammasome overactivation through microbiota-derived isobutyric acid","volume":"16","author":"Zhou","year":"2025","journal-title":"mBio"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2026.2678426","article-title":"High-fat diet exacerbates experimental colitis by inhibiting lysosomal function via the STAT3-TFEB axis","author":"He","year":"2026","journal-title":"Autophagy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050901","article-title":"Bile acids: Key players in inflammatory bowel diseases","volume":"11","author":"Kriaa","year":"2022","journal-title":"Cells"},{"key":"B9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12944-023-01971-4","article-title":"Altered fecal bile acid composition in active ulcerative colitis","volume":"22","author":"Sommersberger","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i24.3609","article-title":"Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis","volume":"27","author":"Yang","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.cmet.2024.06.008","article-title":"TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response","volume":"36","author":"Zheng","year":"2024","journal-title":"Cell Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"21006","DOI":"10.1038\/s41598-020-76497-1","article-title":"NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet","volume":"10","author":"Sokolova","year":"2020","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2014.12.042","article-title":"Active components alignment of gegenqinlian decoction protects ulcerative colitis by attenuating inflammatory and oxidative stress","volume":"162","author":"Xu","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7942845","article-title":"Scientific evidence of Chinese herbal medicine (Gegen Qinlian decoction) in the treatment of ulcerative colitis","volume":"2022","author":"Huang","year":"2022","journal-title":"Gastroenterol Res Pract"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ph18111718","article-title":"Natural nanoparticles in Gegen\u2013Qinlian decoction promote the colonic absorption of active constituents in mice with dextran sulfate sodium-induced ulcerative colitis","volume":"18","author":"Mu","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111896","article-title":"GeGen QinLian decoction alleviate influenza virus infectious pneumonia through intestinal flora","volume":"141","author":"Deng","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412865","article-title":"Quercetin\u2010driven Akkermansia muciniphila alleviates obesity by modulating bile acid metabolism via an ILA\/m6 A\/CYP8B1 signaling","volume":"12","author":"Liu","year":"2025","journal-title":"Adv Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40168-024-02011-8","article-title":"Microbiota governs host chenodeoxycholic acid glucuronidation to ameliorate bile acid disorder induced diarrhea","volume":"13","author":"Lin","year":"2025","journal-title":"Microbiome"},{"key":"B19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12929-025-01206-x","article-title":"Pyroptosis in ulcerative colitis: Biomarkers and therapeutic targets","volume":"32","author":"Cruz","year":"2025","journal-title":"J BioMed Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.11.303","article-title":"AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: Expert review","volume":"166","author":"Hashash","year":"2024","journal-title":"Gastroenterology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2020.05.026","article-title":"Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis","volume":"19","author":"Fritsch","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000042266","article-title":"Efficacy and safety of Gegen Qinlian decoction combined with mesalazine for the treatment of UC: A meta-analysis and systematic review","volume":"104","author":"Chen","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153631","article-title":"Dihydroberberine, an isoquinoline alkaloid, exhibits protective effect against dextran sulfate sodium-induced ulcerative colitis in mice","volume":"90","author":"Li","year":"2021","journal-title":"Phytomedicine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41401-020-0411-9","article-title":"Baicalin prevents LPS-induced activation of TLR4\/NF-\u03baB p65 pathway and inflammation in mice via inhibiting the expression of CD14","volume":"42","author":"Fu","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118012","article-title":"Baicalin n-butyl ester alleviates inflammatory bowel disease and inhibits pyroptosis through the ROS\/ERK\/P-ERK\/NLRP3 pathway in vivo and in vitro","volume":"186","author":"Guo","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157054","article-title":"Coptisine activates aryl hydrocarbon receptor to regulate colonic epithelial homeostasis in DSS induced ulcerative colitis and TNF-\u03b1 challenged intestinal organoids","volume":"145","author":"Tan","year":"2025","journal-title":"Phytomedicine"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104603","article-title":"Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-\u03baB pathway","volume":"152","author":"Li","year":"2020","journal-title":"Pharmacol Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00214","article-title":"Gut microbiota-regulated pharmacokinetics of berberine and active metabolites in beagle dogs after oral administration","volume":"9","author":"Feng","year":"2018","journal-title":"Front Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21030337","article-title":"Role of intestinal microbiota in baicalin-induced drug interaction and its pharmacokinetics","volume":"21","author":"Noh","year":"2016","journal-title":"Molecules"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2015.02.002","article-title":"Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-\u03baB and NLRP3 inflammasome activation","volume":"94","author":"Sun","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21040523","article-title":"Glycyrrhetic acid ameliorates dextran sulfate sodium-induced ulcerative colitis in vivo","volume":"21","author":"Jeon","year":"2016","journal-title":"Molecules"},{"key":"B32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s43556-024-00207-w","article-title":"Ulcerative colitis: Molecular insights and intervention therapy","volume":"5","author":"Liang","year":"2024","journal-title":"Mol BioMed"},{"key":"B33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.clnu.2019.02.037","article-title":"Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: A 6-month randomized controlled-feeding trial","volume":"39","author":"Wan","year":"2020","journal-title":"Clin Nutr"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: Regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2024-100074","article-title":"Bile acids regulation of cellular stress responses in liver physiology and diseases","volume":"2","author":"Li","year":"2024","journal-title":"eGastroenterology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2290315","article-title":"Gut microbiota-derived 12-ketolithocholic acid suppresses the IL-17A secretion from colonic group 3 innate lymphoid cells to prevent the acute exacerbation of ulcerative colitis","volume":"15","author":"Li","year":"2023","journal-title":"Gut Microbes"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/ismejo\/wrag028","article-title":"Gut microbial production of lithocholic acid reprograms pro-resolutive macrophages to enhance vedolizumab responsiveness via the TGR5\/FXR\u2013NF-\u03baB axis","volume":"20","author":"Han","year":"2026","journal-title":"ISME J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23081899","article-title":"Binding affinity via docking: Fact and fiction","volume":"23","author":"Pantsar","year":"2018","journal-title":"Molecules"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-023-00374-8","article-title":"Gut microbiota-mediated secondary bile acid alleviates Staphylococcus aureus-induced mastitis through the TGR5-cAMP-PKA-NF-\u03baB\/NLRP3 pathways in mice","volume":"9","author":"Zhao","year":"2023","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102618","article-title":"Bile acids activate NLRP3 inflammasome, promoting murine liver inflammation or fibrosis in a cell type-specific manner","volume":"10","author":"Holtmann","year":"2021","journal-title":"Cells"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.374","article-title":"Pyroptosis and inflammasomes in cancer and inflammation","volume":"4","author":"Wang","year":"2023","journal-title":"MedComm"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1895206\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:42:27Z","timestamp":1790833347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1895206\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2026.1895206"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1895206","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1895206"}}